• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一个乳腺癌/卵巢癌家族中,一个大片段缺失破坏了BRCA2基因的外显子3转录激活结构域。

A large deletion disrupts the exon 3 transcription activation domain of the BRCA2 gene in a breast/ovarian cancer family.

作者信息

Nordling M, Karlsson P, Wahlström J, Engwall Y, Wallgren A, Martinsson T

机构信息

Department of Clinical Genetics, Sahlgrenska University Hospital, Gothenburg University, Sweden.

出版信息

Cancer Res. 1998 Apr 1;58(7):1372-5.

PMID:9537232
Abstract

We describe the identification of a large deletion in the BRCA2 gene as the disease-causing mutation in a Swedish breast/ovarian cancer family. The 5068-bp deletion encompassed the 3' region of exon 3, including the 3' splice site and most of intron 3, and it resulted on the mRNA level in an inframe exon 3 skipping. The junction site also included an insertion of 4 bp (CCAT). The mutation (nt504del5068insCCAT) resulted in a genotype absent of the two transcription activation regions localized to exon 3. The breast cancer phenotype associated with the described mutation resembled the phenotype of breast cancer found in both BRCA1 and BRCA2 mutation carriers. This is the first report of a large deletion as the disease-causing mutation in the BRCA2 gene.

摘要

我们描述了在一个瑞典乳腺癌/卵巢癌家族中,鉴定出BRCA2基因的一个大片段缺失为致病突变。这个5068bp的缺失涵盖了外显子3的3'区域,包括3'剪接位点和大部分内含子3,在mRNA水平上导致了外显子3的框内跳跃。连接位点还包括一个4bp(CCAT)的插入。该突变(nt504del5068insCCAT)导致外显子3中两个转录激活区域的基因型缺失。与所描述的突变相关的乳腺癌表型类似于在BRCA1和BRCA2突变携带者中发现的乳腺癌表型。这是关于BRCA2基因中大片段缺失作为致病突变的首次报道。

相似文献

1
A large deletion disrupts the exon 3 transcription activation domain of the BRCA2 gene in a breast/ovarian cancer family.在一个乳腺癌/卵巢癌家族中,一个大片段缺失破坏了BRCA2基因的外显子3转录激活结构域。
Cancer Res. 1998 Apr 1;58(7):1372-5.
2
Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease. Mutations in brief no. 224. Online.对BRCA1和BRCA2基因的突变分析发现,在16个佛兰芒乳腺癌和/或卵巢癌家族中的6个家族中存在新的和复发性突变,但在12例早发性散发性患者中未发现此类突变。简短编号224中的突变。在线版。
Hum Mutat. 1999;13(3):256. doi: 10.1002/(SICI)1098-1004(1999)13:3<256::AID-HUMU12>3.0.CO;2-M.
3
The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.家族性前列腺癌中乳腺癌易感基因BRCA1和BRCA2的种系突变频率。癌症研究运动/英国前列腺癌研究组英国家族性前列腺癌研究协作组。
Cancer Res. 2000 Aug 15;60(16):4513-8.
4
Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.来自高危法裔加拿大乳腺癌/卵巢癌家族的乳腺癌病例中ATR序列变异的突变分析与特征描述
BMC Cancer. 2006 Sep 29;6:230. doi: 10.1186/1471-2407-6-230.
5
Screening for BRCA2 mutations in 81 Dutch breast-ovarian cancer families.对81个荷兰乳腺癌-卵巢癌家族进行BRCA2基因突变筛查。
Br J Cancer. 2000 Jan;82(1):151-6. doi: 10.1054/bjoc.1999.0892.
6
A novel germline in frame deletion (4128del3) of the BRCA2 gene detected in a breast/ovarian cancer family with fallopian tube and brain tumors identified in the north of France.
Hum Mutat. 2001 Feb;17(2):155. doi: 10.1002/1098-1004(200102)17:2<155::AID-HUMU15>3.0.CO;2-C.
7
A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes.冰岛具有不同癌症表型的男性和女性乳腺癌家族中的单个BRCA2突变。
Nat Genet. 1996 May;13(1):117-9. doi: 10.1038/ng0596-117.
8
BRCA2 mutations in primary breast and ovarian cancers.原发性乳腺癌和卵巢癌中的BRCA2基因突变。
Nat Genet. 1996 Jun;13(2):238-40. doi: 10.1038/ng0696-238.
9
Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families.丹麦高危乳腺癌-卵巢癌家族中BRCA1和BRCA2基因的大片段重排
Breast Cancer Res Treat. 2009 May;115(2):315-23. doi: 10.1007/s10549-008-0088-0. Epub 2008 Jun 12.
10
A deletion/insertion mutation in the BRCA2 gene in a breast cancer family: a possible role of the Alu-polyA tail in the evolution of the deletion.
Genes Chromosomes Cancer. 2001 May;31(1):91-5. doi: 10.1002/gcc.1110.

引用本文的文献

1
Biallelic BRCA2 variants induce premature ovarian insufficiency by impaired meiotic homologous recombination.双等位基因BRCA2变异通过损害减数分裂同源重组诱导卵巢早衰。
Commun Biol. 2025 Jul 25;8(1):1104. doi: 10.1038/s42003-025-08426-9.
2
BRCA Mutations-The Achilles Heel of Breast, Ovarian and Other Epithelial Cancers.BRCA 基因突变——乳腺癌、卵巢癌和其他上皮性癌症的阿喀琉斯之踵。
Int J Mol Sci. 2023 Mar 5;24(5):4982. doi: 10.3390/ijms24054982.
3
Clinical, splicing, and functional analysis to classify BRCA2 exon 3 variants: Application of a points-based ACMG/AMP approach.
临床、剪接和功能分析对 BRCA2 外显子 3 变异体进行分类:基于 ACMG/AMP 评分的方法应用。
Hum Mutat. 2022 Dec;43(12):1921-1944. doi: 10.1002/humu.24449. Epub 2022 Oct 23.
4
Full in-frame exon 3 skipping of confers high risk of breast and/or ovarian cancer.第3外显子完全框内跳跃会增加患乳腺癌和/或卵巢癌的高风险。
Oncotarget. 2018 Apr 3;9(25):17334-17348. doi: 10.18632/oncotarget.24671.
5
BRCA2 suppresses replication stress-induced mitotic and G1 abnormalities through homologous recombination.BRCA2通过同源重组抑制复制应激诱导的有丝分裂和G1期异常。
Nat Commun. 2017 Sep 13;8(1):525. doi: 10.1038/s41467-017-00634-0.
6
BRCA-associated ovarian cancer: from molecular genetics to risk management.BRCA相关的卵巢癌:从分子遗传学至风险管理
Biomed Res Int. 2014;2014:787143. doi: 10.1155/2014/787143. Epub 2014 Jul 22.
7
Large BRCA1 and BRCA2 genomic rearrangements in Polish high-risk breast and ovarian cancer families.波兰高危乳腺癌和卵巢癌家族中的大 BRCA1 和 BRCA2 基因组重排。
Mol Biol Rep. 2013 Dec;40(12):6619-23. doi: 10.1007/s11033-013-2775-0. Epub 2013 Sep 25.
8
Functional evaluation of BRCA2 variants mapping to the PALB2-binding and C-terminal DNA-binding domains using a mouse ES cell-based assay.利用基于小鼠胚胎干细胞的测定法,对定位于 PALB2 结合和 C 末端 DNA 结合结构域的 BRCA2 变异体进行功能评估。
Hum Mol Genet. 2012 Sep 15;21(18):3993-4006. doi: 10.1093/hmg/dds222. Epub 2012 Jun 7.
9
An entire exon 3 germ-line rearrangement in the BRCA2 gene: pathogenic relevance of exon 3 deletion in breast cancer predisposition.BRCA2 基因外显子 3 全部胚系重排:乳腺癌易感性中外显子 3 缺失的致病性相关性。
BMC Med Genet. 2011 Sep 22;12:121. doi: 10.1186/1471-2350-12-121.
10
Expression of EMSY gene in sporadic ovarian cancer.EMSY 基因在散发性卵巢癌中的表达。
Mol Biol Rep. 2011 Jan;38(1):359-63. doi: 10.1007/s11033-010-0116-0. Epub 2010 Mar 28.